Arkolith/Insider Trading/BOLT/Form 4

Laporte Kathleen

DirectorBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed Dec 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Disposed to issuer(D)1K——0
Dec 12, 2025Grant(A)1K——1K
Dec 12, 2025Grant(A)1K——1K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-321152) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Bolt Biotherapeutics, Inc.

Build

Ask your agent about BOLT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-321152"
Ask your agent
Use Arkolith to summarize insider buying and selling at Bolt Biotherapeutics, Inc.
over the last 90 days and cite the filings.